Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy

scientific article published on May 2004

Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/10430340460745829
P698PubMed publication ID15144580
P5875ResearchGate publication ID8560698

P50authorAkseli HemminkiQ26920981
David T. CurielQ64384545
P2093author name stringMaaike Everts
Minghui Wang
Ronald D Alvarez
Ilya Ulasov
Joanne T Douglas
Dirk M Nettelbeck
Martina Breidenbach
Daniel T Rein
Angel R Rivera
P433issue5
P921main subjectovarian cancerQ172341
AdenoviridaeQ193447
gene therapyQ213901
cancer gene therapyQ124350675
P304page(s)509-518
P577publication date2004-05-01
P1433published inHuman Gene TherapyQ15757580
P1476titleGenetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapy
P478volume15

Reverse relations

cites work (P2860)
Q34008026A conditionally replicative adenovirus, CRAd-S-pK7, can target endometriosis with a cell-killing effect
Q37409025Adenoviral vector-based strategies for cancer therapy
Q33994011Adenovirus receptors and their implications in gene delivery
Q36468656Advanced generation adenoviral virotherapy agents embody enhanced potency based upon CAR-independent tropism
Q40308939An adenovirus serotype 5 vector with fibers derived from ovine atadenovirus demonstrates CAR-independent tropism and unique biodistribution in mice
Q34643252Chapter two--Adenovirus strategies for tissue-specific targeting
Q39892766Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells
Q24683229Current developments in adenovirus-based cancer gene therapy
Q45878552Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.
Q35029126Directing systemic oncolytic viral delivery to tumors via carrier cells
Q37482834Engineered adenovirus fiber shaft fusion homotrimer of soluble TRAIL with enhanced stability and antitumor activity
Q45865369Enhanced local delivery with reduced systemic toxicity: delivery, delivery, and delivery.
Q40350503Infectivity enhancement for adenoviral transduction of canine osteosarcoma cells
Q42189992Novel viral vectors utilizing intron splice-switching to activate genome rescue, expression and replication in targeted cells
Q36318189Oncolytic adenoviruses - selective retargeting to tumor cells
Q35414941Pathology, organ distribution, and immune response after single and repeated intravenous injection of rats with clinical-grade parvovirus H1
Q36315580Recent progress in the battle between oncolytic viruses and tumours
Q38769919Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy.
Q40381616Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice.
Q47148067Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-κB.
Q35609035Transductional targeting of adenovirus vectors for gene therapy

Search more.